Loading company…
ID 439394264 · FY 2019–2024 · 6 years
კომპანიის ძირითად საქმიანობას წარმოადგენს საბითუმო ვაჭრობა ფარმაცევტული საქონლით.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|
| Total Revenue | 2,156 | 2,645 | 4,122 | 4,789 | 6,528 | 5,953 | +22.5% |
| Total COGS | -669 | -855 | -1,463 | -1,476 | -1,647 | -1,791 | +21.8% |
| Gross Profit | 1,487 | 1,790 | 2,659 | 3,313 | 4,881 | 4,162 | +22.9% |
| Gross Margin | 69.0% | 67.7% | 64.5% | 69.2% | 74.8% | 69.9% | |
| Total Operating Expenses | -367 | -421 | -603 | -757 | -966 | -1,182 | +26.4% |
| EBITDA | 1,120 | 1,369 | 2,056 | 2,556 | 3,915 | 2,980 | +21.6% |
| EBITDA Margin | 51.9% | 51.8% | 49.9% | 53.4% | 60.0% | 50.1% | |
| Total D&A | -23 | -24 | -28 | -30 | -59 | -56 | +19.4% |
| EBIT / Operating Income | 1,097 | 1,345 | 2,028 | 2,526 | 3,856 | 2,924 | +21.7% |
| Total Other Income | -0 | -6 | -75 | -169 | -317 | -85 | nmf |
| Profit Before Tax | 1,096 | 1,339 | 1,954 | 2,357 | 3,539 | 2,839 | +21.0% |
| Total Income Tax | -93 | -98 | -154 | -206 | -246 | -198 | +16.3% |
| Net Profit / (Loss) | 1,003 | 1,241 | 1,800 | 2,151 | 3,293 | 2,641 | +21.4% |
| Net Margin | 46.5% | 46.9% | 43.7% | 44.9% | 50.5% | 44.4% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
Ownership & directors from companyinfo.ge (public corporate registry).